Therapy Area topics

Cardiovascular

Central Nervous System

Vantage logo

Biotech’s near-term key catalysts

Important data reveals are expected from Madrigal, Arrowhead and Ascendis, with details from Biogen and Eisai due at a conference.

Diabetes

Vantage logo

Akero’s imperfect Harmony

An apparent hit in Nash has more than doubled the group’s market cap. But are the data all they seem?

Digital Health

Oncology

Various

Vantage logo

Biotech’s near-term key catalysts

Important data reveals are expected from Madrigal, Arrowhead and Ascendis, with details from Biogen and Eisai due at a conference.

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.